Trial Site Detail


QINLOCK Ripretinib DCC-2618
A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Active, not recruiting


Fox Chase Cancer Center

333 Cottman Ave     
Philadelphia , PA 19111


Principal Investigator:
Margeret von Mehren, M.D.
Activation Status of this Site:
Not yet activated
Notes about this Site:
Fox Chase Cancer Center Website:



Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.